{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:44:33Z","timestamp":1762865073202},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.diagmicrobio.2005.12.006","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T13:48:09Z","timestamp":1142344089000},"page":"119-127","source":"Crossref","is-referenced-by-count":52,"title":["Characterization of fluoroquinolone-resistant \u03b2-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997\u20132004)"],"prefix":"10.1016","volume":"55","author":[{"given":"Douglas J.","family":"Biedenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Toleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1517\/13543784.7.5.761","article-title":"Therapeutic advances of new fluoroquinolones","volume":"7","author":"Ball","year":"1998","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0732-8893(97)81807-X","article-title":"Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA","volume":"29","author":"Ballow","year":"1997","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1742-1241.2000.tb10932.x","article-title":"Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated from five countries","volume":"54","author":"Bandak","year":"2000","journal-title":"Int J Clin Prac"},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0732-8893(01)00298-X","article-title":"Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and \u03b2-lactams against Gram-positive bacteria","volume":"41","author":"Bassetti","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.46.1.234-238.2002","article-title":"Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and \u03b2-lactams against Gram-positive clinical isolates","volume":"46","author":"Bassetti","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib6","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/AAC.44.11.3049-3054.2000","article-title":"Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance","volume":"44","author":"Bast","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/AAC.38.9.2183","article-title":"Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci","volume":"38","author":"Betriu","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2004.08.017","article-title":"Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States","volume":"51","author":"Bhavnani","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0732-8893(96)00066-1","article-title":"The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci","volume":"25","author":"Biedenbach","year":"1996","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0732-8893(03)00065-8","article-title":"Antimicrobial susceptibility profile among \u03b2-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program\u2014North America, 2001","volume":"46","author":"Biedenbach","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2005.12.006_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/45.suppl_3.95","article-title":"Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae","volume":"45","author":"Broskey","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib12","series-title":"Performance standards for antimicrobial susceptibility testing. Document M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/45.suppl_1.3","article-title":"Group A streptococci in the 1990s","volume":"45","author":"Efstratiou","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib15","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/AAC.43.10.2520","article-title":"Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci","volume":"43","author":"Ferrandiz","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/430829","article-title":"A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance","volume":"41","author":"Fuller","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib17","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1128\/AAC.42.11.2792","article-title":"Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci","volume":"42","author":"Gonzalez","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0732-8893(02)00374-7","article-title":"Antimicrobial susceptibility patterns of \u03b2-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997\u20132000)","volume":"43","author":"Gordon","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/AAC.44.8.2197-2200.2000","article-title":"Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci","volume":"44","author":"Guerin","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(03)00015-4","article-title":"Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000\u20132001): report from the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Jones","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib21","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1128\/AAC.47.11.3605-3609.2003","article-title":"First Streptococcus agalactiae isolates highly resistant to quinolones with point mutations in gyrA and par C","volume":"47","author":"Kawamura","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s100960100482","article-title":"In vitro activity of gemifloxacin (SB-265805) compared to 11 other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae","volume":"20","author":"Kerawala","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0732-8893(86)90069-6","article-title":"Penicillin tolerant group A streptococci","volume":"4","author":"Krasinski","year":"1986","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib24","series-title":"Methods for dilution antimicrobial susceptibility testes for bacteria that grow aerobically. Document M7-A6","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0732-8893(97)81810-X","article-title":"Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin","volume":"29","author":"Pfaller","year":"1997","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/AAC.49.5.2130-2132.2005","article-title":"Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones","volume":"49","author":"Powis","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/340352","article-title":"Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis","volume":"34","author":"Razonable","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkf036","article-title":"Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones","volume":"49","author":"Reinert","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1469-0691.2004.00890.x","article-title":"High-level fluoroquinolone resistance in a clinical Streptococcus pyogenes isolate in Germany","volume":"10","author":"Reinert","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/432473","article-title":"Macrolide-resistant Steptococcus pyogenes in the United States, 2002\u20132003","volume":"41","author":"Richter","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1469-0691.2005.01216.x","article-title":"Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain","volume":"11","author":"Rivera","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.diagmicrobio.2005.12.006_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/13.4.389","article-title":"Antimicrobial tolerance in group C and group G streptococci","volume":"13","author":"Rolston","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0732-8893(03)00115-9","article-title":"In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients","volume":"47","author":"Rolston","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dki315","article-title":"Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003","volume":"56","author":"Schurek","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. B","key":"10.1016\/j.diagmicrobio.2005.12.006_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/39.suppl_2.57","article-title":"The in vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria","volume":"39","author":"Sefton","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dki286","article-title":"Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004","volume":"56","author":"Tamayo","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0732-8893(94)90089-2","article-title":"Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use","volume":"18","author":"Waites","year":"1994","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib38","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/AAC.49.6.2495-2497.2005","article-title":"Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance","volume":"49","author":"Wehbeh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.12.006_bib39","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/AAC.44.11.3196-3198.2000","article-title":"Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance","volume":"44","author":"Yan","year":"2000","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288930500355X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288930500355X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:59:47Z","timestamp":1683399587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288930500355X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S073288930500355X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.12.006","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}